Farms.com Home   Ag Industry News

U.S. asks Japan to cut ag tariffs in trade talks

U.S. asks Japan to cut ag tariffs in trade talks

Some U.S. ag already has free access to Japan

By Diego Flammini
Staff Writer
Farms.com

Reducing tariffs on U.S. ag products needs to be part of a bilateral trade agreement between the U.S. and Japan, President Trump said recently.

“We’ll be discussing, very strongly, agriculture,” the president told reporters Monday at the White House during a meeting with Japanese Prime Minister Shinzo Abe. “Because, as the Prime Minister knows, Japan puts very massive tariffs on (U.S.) agriculture.”

Japan is the fourth-largest importer of U.S. ag commodities. The country’s ag imports from the United States totaled US$12.9 billion in 2018, the USDA says.

Several U.S. ag products already enjoy preferential market access to Japan.

Japan, for example, doesn’t charge tariffs on corn, soybeans or wheat, the American Farm Bureau Federation says.

But products like beef and dairy face 25 and 50 percent tariffs respectively.

President Trump has threatened a 25 percent tariff on Japanese cars if the country doesn’t open more of its market to U.S. ag products.

The U.S. has been on the outside looking in at the Japanese market since President Trump removed America from the Trans-Pacific Partnership (TPP) only three days into his presidency.

Getting a bilateral framework in place now is important to ensure U.S. producers benefit from access to Japan, said Secretary of Agriculture Sonny Perdue.

“We want a quick resolution of our agricultural request here … maybe temporarily that could then be fleshed out over a longer period,” he told reporters Tuesday, Reuters reported.

U.S. farmers should receive the same market access as TPP members, he said.

Farms.com has reached out to the American Farm Bureau and the U.S. Agricultural Export Development Council for comment.


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.